Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
UN chief warns he could refer Israel to ICJ over laws targetting UNRWA - 2Huge solar flare no threat to Artemis 2 astronaut launch to the moon, NASA says
- 35 Must-Attempt Fascinating Dishes from Around the World
- 4Finding Ideal Date Spots for Two or three Encounters
- 5Gen Z workplace stereotypes were TV’s favorite punchline in 2025
- 'The Drama' plot twist, explained: What did Zendaya's character do, and what happens to her wedding?
- Artemis II astronauts race to set a new distance record from Earth and behold the moon's far side
- Discovery of ancient pleasure boat reveals Egypt's maritime history
- The cave was pitch black – so to create this magical underwater shot, the photographer had to use all his camera expertise...
- Auschwitz Committee wants German auction of Holocaust items scrapped
- The Most Compelling Books of the 10 years
- Vote In favor of Your Favored Cereal
- 8 key takeaways from Savannah Guthrie's 'Today' interview on the disappearance of her mother
- Independence from the rat race for Recent college grads: Systems and Tips
